Curriculum Vitaes

Naoko Ishihara

  (石原 尚子)

Profile Information

Affiliation
Associate Professor, School of Medicine Faculty of Medicine, Fujita Health University
Degree
医学博士(名古屋大学)

J-GLOBAL ID
201201082026766796
researchmap Member ID
7000002994

Papers

 67
  • Masafumi Miyata, Arisa Kojima, Yuri Kawai, Hidetoshi Uchida, Hiroko Boda, Naoko Ishihara, Hidehito Inagaki, Tetsushi Yoshikawa, Hiroki Kurahashi
    Human genome variation, 12(1) 2-2, Jan 6, 2025  
    UBA1 is an E1 ubiquitin-activating enzyme that initiates the ubiquitylation of target proteins and is thus a key component of the ubiquitin signaling pathway. Three disorders are associated with pathogenic variants of the UBA1 gene: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome, lung cancer in never smokers (LCINS), and X-linked spinal muscular atrophy (XL-SMA, SMAX2). We here report a case of infantile respiratory distress syndrome followed by continuing neuromuscular symptoms. We identified a de novo hemizygous mutation, c.1660 C > T (p.Pro554Ser), in exon 15 of the UBA1 gene in this baby. This missense mutation was located with the AAD (active adenylation domain) of the protein, a known hotspot of SMAX2 mutations. This case lends support to the genotype-phenotype correlation regarding the UBA1 mutation and its related diseases.
  • 河村 吉紀, 水谷 泰彰, 長尾 龍之介, 朝倉 真生, 小澤 慶, 古川 源, 吉兼 綾美, 石原 尚子, 渡辺 宏久, 吉川 哲史
    NEUROINFECTION, 27(2) 228-228, Oct, 2022  
  • 須藤 湧太, 鈴木 孝典, 跡部 真人, 平井 雅之, 鈴木 大次郎, 小島 有紗, 内田 英利, 齋藤 和由, 畑 忠善, 石原 尚子, 中原 一郎, 吉川 哲史
    日本小児科学会雑誌, 126(8) 1147-1152, Aug, 2022  
    7歳男児。体育の授業中に足を滑らせて顔面から転倒し、2時間後に眩暈・頭痛・嘔吐が出現した。近医を受診し、頭部MRIで左小脳半球に脳梗塞が認められた。発症3ヵ月後に施行されたフォロー目的のMRIで右頭頂葉と右小脳半球に小梗塞を認められ、精査目的で当院に紹介された。脳血管造影で、頸部の右捻転により左椎骨動脈が狭窄する所見と内膜の解離所見を認め、Bow hunter症候群による椎骨動脈解離および多発性脳梗塞と診断した。解離部とその近位の左椎骨動脈のコイル塞栓術を行い、術後4ヵ月の現在まで脳梗塞の再発は認めていない。
  • 須藤 湧太, 鈴木 孝典, 跡部 真人, 平井 雅之, 鈴木 大次郎, 小島 有紗, 内田 英利, 齋藤 和由, 畑 忠善, 石原 尚子, 長谷部 朗子, 中原 一郎, 吉川 哲史
    日本小児科学会雑誌, 126(2) 396-396, Feb, 2022  
  • Yuji Ito, Yuki Maki, Yu Okai, Hiroyuki Kidokoro, Epifanio Bagarinao, Tomoya Takeuchi, Atsuko Ohno, Tomohiko Nakata, Naoko Ishihara, Akihisa Okumura, Hiroyuki Yamamoto, Satoshi Maesawa, Jun Natsume
    Pediatrics international : official journal of the Japan Pediatric Society, 64(1) e15001, Sep 25, 2021  
    BACKGROUND: We aimed to investigate electroencephalography (EEG)-functional magnetic resonance imaging (fMRI) findings to elucidate the interictal epileptiform discharge (IED)-related functional alterations in deep brain structures as well as the neocortex in childhood epilepsy with centrotemporal spikes (CECTS). METHODS: Ten children with CECTS (median age; 8.2 years) referred to our hospital within a year of onset were eligible for inclusion. They underwent EEG-fMRI recording during sleep. In addition, longitudinal evaluations, including medical examinations, intelligence tests, and questionnaires about developmental disabilities, were performed. The initial evaluation was performed at the same time as the EEG-fMRI, and the second evaluation was performed over 2 years after the initial evaluation. RESULTS: Three children were unable to maintain sleep during the EEG-fMRI recording, and the remaining seven children were eligible for further assessment. All patients showed unilateral-dominant centrotemporal spikes during scans. One patient had only positive hemodynamic responses, while the others had both positive and negative hemodynamic responses. All patients showed IED-related hemodynamic responses in the bilateral neocortex. For deep brain structures, IED-related hemodynamic responses were observed in the cingulate gyrus (n=4), basal ganglia (n=3), thalamus (n=2), and default mode network (n=1). Seizure frequencies at the second evaluation were infrequent or absent, and the longitudinal results of intelligence tests and questionnaires were within normal ranges. CONCLUSIONS: We demonstrated that IEDs affect broad brain areas, including deep brain structures such as cingulate gyrus, basal ganglia, and thalamus. Deep brain structures may play an important role in the pathophysiology of CECTS.
  • 赤松 真実, 古川 源, 小澤 慶, 三浦 浩樹, 河村 吉紀, 石原 尚子, 吉川 哲史
    NEUROINFECTION, 26(2) 46-46, Sep, 2021  
  • 石原 尚子, 宮田 昌史, 久保田 一生, 才津 浩智, 下澤 伸行
    脳と発達, 53(Suppl.) S243-S243, May, 2021  
  • 吉兼 綾美, 古川 源, 河村 吉紀, 工藤 寿子, 吉川 哲史, 石原 尚子
    脳と発達, 53(Suppl.) S266-S266, May, 2021  
  • 古川 源, 木曽原 悟, 河村 吉紀, 石原 尚子, 吉川 哲史
    脳と発達, 53(Suppl.) S216-S216, May, 2021  
  • Misa Miyake, Yoshiki Kawamura, Naoko Ishihara, Shigetaka Suzuki, Hiroki Miura, Yoko Sakaguchi, Masaharu Tanaka, Yoshiyuki Takahashi, Seiji Kojima, Hiroshi Toyama, Jun Natsume, Tetsushi Yoshikawa
    Microorganisms, 9(4), Apr 8, 2021  
    The aim of this study was to determine whether human herpesvirus 6B (HHV-6B) infection can impair the hippocampus in pediatric hematopoietic stem cell transplant (HSCT) recipients. Study subjects were pediatric HSCT recipients monitored for HHV-6B infection who underwent brain MRI before and after transplantation. Volumetric analysis of the hippocampus was performed. Of the 107 patients that received HSCT at Nagoya University Hospital Between July 2008 and April 2014, 20 were eligible for volumetric analysis. Eight patients had HHV-6B infection, of whom two had encephalopathy at the time of HHV-6B infection. None of the 12 patients without HHV-6B infection had encephalopathy. The median ratio of the right hippocampal volume from before to after transplantation was 0.93 in patients with HHV-6B infection and 1.02 in without HHV-6B infection (p = 0.007). The median ratio of the left hippocampal volume ratio in patients with and without HHV-6B infection was 0.92 and 1.00, respectively (p = 0.003). Among the eight patients with HHV-6B infection, four had a marked reduction in hippocampal volume (volume ratio < 0.90). Only one of these patients had neurological symptoms at the time of HHV-6B infection. The reduction in the hippocampal volume ratio was higher in pediatric HSCT recipients with HHV-6B infection than those without viral infection. Neurological follow-up may be required for pediatric HSCT recipients with HHV-6B infection.
  • 吉兼 綾美, 石原 尚子, 三宅 未紗, 石丸 聡一郎, 河村 吉紀, 吉川 哲史
    日本小児科学会雑誌, 125(2) 272-272, Feb, 2021  
  • Jun Natsume, Naoko Ishihara, Yoshiteru Azuma, Tomohiko Nakata, Tomoya Takeuchi, Masaharu Tanaka, Yoko Sakaguchi, Yu Okai, Yuji Ito, Hiroyuki Yamamoto, Atsuko Ohno, Hiroyuki Kidokoro, Ayako Hattori, Shin Nabatame, Katsuhiko Kato
    Brain & development, 43(1) 69-77, Jan, 2021  Peer-reviewed
    PURPOSE: To establish an objective method of [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) that can assist in the diagnosis of glucose transporter 1 deficiency syndrome (GLUT1-DS). METHODS: FDG-PET was performed in 8 patients with a mean age of 12.5 years (range, 2-22 years) with GLUT1-DS. Their PET findings were compared with those of 45 controls with a mean age of 11.2 years (range, 2-21 years) by statistical parametric mapping (SPM12, Welcome Neurological Institute). The controls had epilepsy of unknown etiology and normal MRI findings. The age-adjusted ratios of mean radioactivities in regions of interest (ROIs) of bilateral lenticular nuclei, thalami, and the whole cerebral cortex were also measured. The sensitivities and specificities of the ratios for the differential diagnosis of GLUT1-DS were also determined. RESULTS: SPM showed significantly decreased uptake in bilateral thalami and increased uptake in bilateral lenticular nuclei in patients with GLUT1-DS. There were no areas in the cerebral cortex with significant differences between patients and controls. On ROI analysis, by setting the cut-off value of the age-adjusted lenticular nuclei/thalami radioactivity ratio to 1.54, patients with GLUT1-DS were differentiated from controls with sensitivity of 1.00 and specificity of 0.98. CONCLUSION: The age-adjusted lenticular nuclei/thalami radioactivity ratio on PET can distinguish patients with GLUT1-DS from patients with epilepsy of unknown etiology with high sensitivity and specificity. It is important to pay attention to the metabolism of the lenticular nuclei and thalami on PET for the diagnosis of GLUT1-DS.
  • 吉兼 綾美, 石原 尚子, 古川 源, 石丸 聡一郎, 三宅 未紗, 河村 吉紀, 吉川 哲史
    臨床神経生理学, 48(5) 530-530, Oct, 2020  
  • Tomoyuki Akiyama, Yuki Hyodo, Kosei Hasegawa, Taikan Oboshi, Katsumi Imai, Naoko Ishihara, Yuri Dowa, Takayoshi Koike, Toshiyuki Yamamoto, Jun Shibasaki, Hiroko Shimbo, Tetsuhiro Fukuyama, Kyoko Takano, Hiroshi Shiraku, Saoko Takeshita, Tohru Okanishi, Shimpei Baba, Masaya Kubota, Shin-Ichiro Hamano, Katsuhiro Kobayashi
    Pediatric neurology, 113 33-41, Sep 2, 2020  Peer-reviewed
    BACKGROUND: We aimed to demonstrate the biochemical characteristics of vitamin B6-dependent epilepsy, with a particular focus on pyridoxal 5'-phosphate and pyridoxal in the cerebrospinal fluid. METHODS: Using our laboratory database, we identified patients with vitamin B6-dependent epilepsy and extracted their data on the concentrations of pyridoxal 5'-phosphate, pyridoxal, pipecolic acid, α-aminoadipic semialdehyde, and monoamine neurotransmitters. We compared the biochemical characteristics of these patients with those of other epilepsy patients with low pyridoxal 5'-phosphate concentrations. RESULTS: We identified seven patients with pyridoxine-dependent epilepsy caused by an ALDH7A1 gene abnormality, two patients with pyridoxal 5'-phosphate homeostasis protein deficiency, and 28 patients with other epilepsies with low cerebrospinal fluid pyridoxal 5'-phosphate concentrations. Cerebrospinal fluid pyridoxal and pyridoxal 5'-phosphate concentrations were low in patients with vitamin B6-dependent epilepsy but cerebrospinal fluid pyridoxal concentrations were not reduced in most patients with other epilepsies with low cerebrospinal fluid pyridoxal 5'-phosphate concentrations. Increase in 3-O-methyldopa and 5-hydroxytryptophan was demonstrated in some patients with vitamin B6-dependent epilepsy, suggestive of pyridoxal 5'-phosphate deficiency in the brain. CONCLUSIONS: Low cerebrospinal fluid pyridoxal concentrations may be a better indicator of pyridoxal 5'-phosphate deficiency in the brain in vitamin B6-dependent epilepsy than low cerebrospinal fluid pyridoxal 5'-phosphate concentrations. This finding is especially helpful in individuals with suspected pyridoxal 5'-phosphate homeostasis protein deficiency, which does not have known biomarkers.
  • Gen Furukawa, Yutaka Negishi, Tomoya Takeuchi, Naoko Ishihara, Akihisa Okumura
    Brain & development, 42(8) 617-620, Sep, 2020  Peer-reviewed
    OBJECTIVES: This study was performed to evaluate the efficacy and tolerability of lacosamide (LCM) for paroxysmal kinesigenic dyskinesia (PKD) in children. METHODS: We retrospectively reviewed the medical charts of pediatric PKD patients (aged <16 years) treated with LCM. Data regarding demographic characteristics, proline-rich transmembrane protein 2 (PRRT2) gene variant, clinical features of PKD, dose of LCM, efficacy, and adverse events were recorded. RESULTS: Four eligible patients (3 males, 1 female) were identified, with an age of onset ranging from 8.3 to 14.7 years. PRRT2 variant was evaluated in three children and a c.649dupC variant was identified in one child with a positive family history. Attacks were bilateral in three children and left-sided in one. Two children had a family history of PKD and one child had a family history of benign infantile epilepsy. Treatment with carbamazepine failed in two children due to drowsiness and auditory disturbance. The initial dose of LCM was 50 mg/day in three children and 100 mg/day in one. All patients were attack-free within a few days. The maintenance dose was mostly similar to the initial dose. No adverse events related to LCM were reported during follow-up. CONCLUSIONS: LCM is an effective and well-tolerated treatment for PKD in children, and low-dose treatment may be viable.
  • 古川 源, 石原 尚子, 高亀 弘隆, 村山 和宏, 石丸 聡一郎, 河村 吉紀, 松本 省二, 中原 一郎, 吉川 哲史
    脳と発達, 52(5) 335-336, Sep, 2020  
  • Chikako Ogawa, Hiroyuki Kidokoro, Naoko Ishihara, Takeshi Tsuji, Hirokazu Kurahashi, Ayako Hattori, Motomasa Suzuki, Shunsuke Ogaya, Yuji Ito, Tatsuya Fukasawa, Tetsuo Kubota, Akihisa Okumura, Shinji Saitoh, Jun Natsume
    Pediatric neurology, 109 79-84, Aug, 2020  Peer-reviewed
    OBJECTIVE: To investigate clinical risk factors for acute magnetic resonance imaging (MRI) abnormalities in patients with benign convulsions with mild gastroenteritis or benign infantile epilepsy. STUDY DESIGN: We investigated clinical and diffusion-weighted imaging findings in 32 patients with benign convulsions with mild gastroenteritis and 22 patients with benign infantile epilepsy who underwent MRI within seven days of seizure onset between 2010 and 2015. RESULTS: Diffusion-weighted imaging showed signal hyperintensity in the splenium of the corpus callosum in seven patients with benign convulsions with mild gastroenteritis, but no abnormalities in patients with benign infantile epilepsy. Patients with benign convulsions with mild gastroenteritis with splenial lesions showed a higher rate of rotavirus detection from feces (P = 0.006), higher serum level of C-reactive protein (P = 0.04), and shorter interval between seizure onset and MRI (P = 0.002) than patients with benign convulsions with mild gastroenteritis without splenial lesions. Multivariate analysis revealed rotavirus infection as a significant risk factor for splenial lesions on diffusion-weighted imaging in patients with benign convulsions with mild gastroenteritis (P = 0.02). CONCLUSIONS: Splenial lesions are often seen during acute period in patients with benign convulsions with mild gastroenteritis. Rotavirus infection is a risk factor for splenial lesions in patients with benign convulsions with mild gastroenteritis, suggesting the role of rotavirus to cause edema in the corpus callosum. From our observations, benign convulsions with mild gastroenteritis with a splenial lesion on diffusion-weighted imaging suggests good outcomes, and extensive evaluation of these patients may be unnecessary.
  • Misa Miyake, Yoshiki Kawamura, Fumihiko Hattori, Hiroki Miura, Naoko Ishihara, Tetsushi Yoshikawa
    Pediatric neurology, 109 52-55, Aug, 2020  
    BACKGROUND: It is well known that febrile seizures are commonly occur in children with exanthem subitum. In this study, we compared the clinical features and backgrounds of patients with complex febrile seizures with and without primary human herpesvirus 6B infection. METHODS: Sixty-two patients were enrolled after experiencing their first febrile seizure. Primary human herpesvirus 6B infection was confirmed when human herpesvirus 6B DNA was detected and human herpesvirus 6B antibody was negative in serum obtained during the acute phase of infection. Patient age, gender, and features of seizures were evaluated between patients with and without human herpesvirus 6B infection. RESULTS: Thirty patients with complex febrile seizure were diagnosed with primary human herpesvirus 6B infection. Those with primary human herpesvirus 6B infection (median, 13 months; range, seven to 39 months) were significantly younger than those without primary human herpesvirus 6B infection (median, 19 months; range, 10 to 59 months) (P = 0.001), and the proportion of males was significantly higher in patients without primary human herpesvirus 6B infection (male/female, 25/7) than in those with the infection (male/female, 14/16) (P = 0.017). An interval between fever onset and seizures of more than 24 hours was significantly more common in patients with primary human herpesvirus 6B infection (15 of the 30 patients) than in those without primary HHV-6B infection (two of 32 patients) (P < 0.001). CONCLUSIONS: A younger age at onset, a different gender ratio compared with febrile seizure due to other causes, and the length of interval between fever and seizures were features of complex febrile seizure associated human herpesvirus 6B infection. These findings may suggest a mechanism of complex febrile seizure onset different from that due to other causes.
  • 須藤 湧太, 三浦 浩樹, 小澤 慶, 河村 吉紀, 石丸 聡一郎, 赤松 北斗, 田中 真己人, 石原 尚子, 工藤 寿子, 吉川 哲史
    日本小児科学会雑誌, 124(3) 594-594, Mar, 2020  
  • 内田 英利, 畑 忠善, 小島 有紗, 江竜 喜彦, 齋藤 和由, 石原 尚子, 吉川 哲史
    日本小児科学会雑誌, 124(2) 327-327, Feb, 2020  
  • Akihisa Okumura, Keiko Shimojima, Hirokazu Kurahashi, Shingo Numoto, Shino Shimada, Atsushi Ishii, Iori Ohmori, Satoru Takahashi, Tomonari Awaya, Tetsuo Kubota, Takafumi Sakakibara, Naoko Ishihara, Ayako Hattori, Hiroyuki Torisu, Jun Tohyama, Takeshi Inoue, Akiko Haibara, Takuji Nishida, Yukihiro Yuhara, Kazushi Miya, Ryuta Tanaka, Shinichi Hirose, Toshiyuki Yamamoto
    Seizure, 71 1-5, Oct, 2019  
    PURPOSE: This study was performed to clarify the clinical features of Japanese patients with PRRT2 mutations. METHODS: The PRRT2 gene was analyzed in 135 patients with benign infantile epilepsy (BIE) or paroxysmal kinesigenic dyskinesia (PKD) using a direct sequencing method: 92 patients had BIE alone, 25 had both BIE and PKD, and 18 had PKD alone. Of the cases, 105 were familial, and 30 were sporadic. Clinical information was collected using a structured questionnaire. RESULTS: PRRT2 mutations were identified in 104 patients. Among the familial cases, PRRT2 mutations were found in at least one individual in 21 of 28 families with BIE alone, in 26 of 27 families with infantile convulsions and choreoathetosis, and in 2 of 3 families with PKD alone. Among the sporadic cases, PRRT2 mutations were observed in 7 of 25 patients with BIE alone, in 1 of 1 patient with BIE and PKD, and in 3 of 4 patients with PKD alone. The c.649dupC mutation was the most frequent, followed by the c.981C > G mutation. Among the patients with epilepsy, the median age at BIE onset was 5 months, the median age at the last seizure was 6 months, and the median number of seizures was 5. CONCLUSION: PRRT2 mutations were found in 68% of Japanese probands with BIE or PKD. The phenotypes of BIE associated with PRRT2 mutations were consistent with those of BIE diagnosed clinically.
  • 三宅 未紗, 石原 尚子, 石丸 聡一郎, 河村 吉紀, 田中 真己人, 吉川 哲史
    てんかん研究, 37(2) 575-575, Sep, 2019  
  • 小澤 慶, 石丸 聡一郎, 三浦 浩樹, 河村 吉紀, 田中 真己人, 石原 尚子, 工藤 寿子, 吉川 哲史
    NEUROINFECTION, 24(2) 152-152, Sep, 2019  
  • 古川 源, 石原 尚子, 石丸 聡一郎, 三宅 未紗, 河村 吉紀, 吉川 哲史
    てんかん研究, 37(2) 593-593, Sep, 2019  
  • 石原 尚子, 石丸 聡一郎, 河村 吉紀, 吉川 哲史
    脳と発達, 51(Suppl.) S331-S331, May, 2019  
  • 石丸 聡一郎, 河村 吉紀, 小澤 慶, 三浦 浩樹, 石原 尚子, 島 さゆり, 武藤 多津郎, 吉川 哲史
    脳と発達, 51(Suppl.) S238-S238, May, 2019  
  • Naoko Ishihara, Hidehito Inagaki, Misa Miyake, Yoshiki Kawamura, Tetsushi Yoshikawa, Hiroki Kurahashi
    Brain & development, 41(3) 285-291, Mar, 2019  Peer-reviewed
  • Shinji Itamura, Tohru Okanishi, Yoshifumi Arai, Mitsuyo Nishimura, Shimpei Baba, Naoki Ichikawa, Yoshimichi Hirayama, Naoko Ishihara, Takuya Hiraide, Hidetoshi Ishigaki, Tokiko Fukuda, Yoshiro Otsuki, Hideo Enoki, Ayataka Fujimoto
    Frontiers in neurology, 10 1233-1233, 2019  Peer-reviewed
    Hemiconvulsion-hemiplegia-epilepsy syndrome (HHES) is a subset of acute encephalopathy characterized by infantile-onset with acute hemiconvulsive febrile status and subsequent unilateral cerebral atrophy and hemiparesis. In the chronic phase, patients with HHES develop epilepsy, typically displayed as intractable focal seizures. The patients are often intractable with antiepileptic drugs and need surgical treatment. Although viral encephalitis and genetic abnormalities are presumed to be the underlying etiology, the pathogenesis remains mostly unknown. We describe three cases of successful functional hemispherotomy for intractable epilepsy in HHES. Patients developed acute asymmetrical convulsive status following viral infections during the ages of 17-30 months. Their seizures were intractable with antiepileptic drugs and required hemispherotomy. On the basis of the pathological findings, all cases were diagnosed as focal cortical dysplasia (FCD) type IIId. The epileptogenic mild cortical malformations may be the cause of HHES.
  • 石丸 聡一郎, 河村 吉紀, 小澤 慶, 三浦 浩樹, 石原 尚子, 島 さゆり, 武藤 多津郎, 吉川 哲史
    NEUROINFECTION, 23(2) 186-186, Oct, 2018  
  • 市野 学, 佐々木 ひと美, 深谷 孝介, 引地 克, 高原 健, 深見 直彦, 日下 守, 石原 尚子, 倉橋 浩樹, 白木 良一
    日本小児泌尿器科学会雑誌, 27(2) 228-228, Jun, 2018  
  • Chikako Ogawa, Hiroyuki Kidokoro, Tatsuya Fukasawa, Hiroyuki Yamamoto, Naoko Ishihara, Yuji Ito, Yoko Sakaguchi, Yu Okai, Atsuko Ohno, Tomohiko Nakata, Yoshiteru Azuma, Ayako Hattori, Tetsuo Kubota, Takeshi Tsuji, Akihiro Hirakawa, Hisashi Kawai, Jun Natsume
    Epilepsia, 59(2) 440-448, Feb, 2018  
    OBJECTIVE: To clarify longitudinal changes in white matter microstructures from the onset of disease in patients with West syndrome (WS) of unknown etiology. METHODS: Diffusion tensor imaging (DTI) was prospectively performed at onset and at 12 and 24 months old in 17 children with WS of unknown etiology. DTI was analyzed using tract-based spatial statistics (TBSS) and tract-specific analysis (TSA) of 13 fiber tracts, and fractional anisotropy (FA) and mean diffusivity (MD) were compared with those of 42 age-matched controls. Correlations of FA and MD with developmental quotient (DQ) at age 24 months were analyzed. Multiple comparisons were adjusted for using the false discovery rate (q-value). RESULTS: TBSS analysis at onset showed higher FA and lower MD in the corpus callosum and brainstem in patients. TSA showed lower MD in bilateral uncinate fasciculi (UF) (right: q < 0.001; left: q = 0.03) at onset in patients. TBSS showed a negative correlation between FA at onset and DQ in the right frontal lobe, whereas FA at 24 months old exhibited a positive correlation with DQ in the diffuse white matter. MD for bilateral UF at 24 months old on TSA correlated positively with DQ (q = 0.04, both). SIGNIFICANCE: These findings may indicate the existence of cytotoxic edema in the immature white matter and dorsal brainstem at onset, and subsequent alterations in the diffuse white matter in WS of unknown etiology. Microstructural development in the UF might play important roles in cognitive development in WS.
  • 山本 啓之, 寳珠山 稔, 三宅 未紗, 石丸 聡一郎, 石原 尚子, 前澤 聡, 田中 雅大, 岡井 佑, 坂口 陽子, 大野 敦子, 中田 智彦, 城所 博之, 夏目 淳
    てんかん研究, 35(2) 550-550, Sep, 2017  
  • Tomoya Takeuchi, Jun Natsume, Hiroyuki Kidokoro, Naoko Ishihara, Hiroyuki Yamamoto, Yoshiteru Azuma, Yuji Ito, Naoko Kurahashi, Takeshi Tsuji, Motomasa Suzuki, Kazuya Itomi, Keitaro Yamada, Hirokazu Kurahashi, Shinpei Abe, Akihisa Okumura, Koichi Maruyama, Tamiko Negoro, Kazuyoshi Watanabe, Seiji Kojima
    BRAIN & DEVELOPMENT, 38(8) 723-730, Sep, 2016  Peer-reviewed
  • Chikako Ogawa, Jun Natsume, Hiroyuki Yamamoto, Naoko Ishihara, Atsushi Tashiro, Hiroyuki Kidokoro, Tamiko Negoro, Mari Yoshida, Kazuyoshi Watanabe
    Seizure, 35 80-2, Feb, 2016  
  • Hiroyuki Yamamoto, Jun Natsume, Hiroyuki Kidokoro, Naoko Ishihara, Motomasa Suzuki, Takeshi Tsuji, Tetsuo Kubota, Akio Yamada, Michio Ozeki, Zenichiro Kato, Yoshiki Kawamura, Tetsushi Yoshikawa, Akihisa Okumura, Naoki Ando, Shinji Saitoh, Yoshiyuki Takahashi, Kazuyoshi Watanabe, Seiji Kojima
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 19(6) 672-678, Nov, 2015  Peer-reviewed
  • Jun Natsume, Chikako Ogawa, Tatsuya Fukasawa, Hiroyuki Yamamoto, Naoko Ishihara, Yoko Sakaguchi, Yuji Ito, Tomoya Takeuchi, Yoshiki Azuma, Naoki Ando, Tetsuo Kubota, Takeshi Tuji, Hisashi Kawai, Shinji Naganawa, Hiroyuki Kidokoro
    AJNR Am J Neuroradiol., Nov, 2015  
  • Setsuri Yokoi, Naoko Ishihara, Fuyuki Miya, Makiko Tsutsumi, Itaru Yanagihara, Naoko Fujita, Hiroyuki Yamamoto, Mitsuhiro Kato, Nobuhiko Okamoto, Tatsuhiko Tsunoda, Mami Yamasaki, Yonehiro Kanemura, Kenjiro Kosaki, Seiji Kojima, Shinji Saitoh, Hiroki Kurahashi, Jun Natsume
    Scientific reports, 5 15165-15165, Oct 23, 2015  Peer-reviewed
  • Yoshiki Kawamura, Ai Nakayama, Taichi Kato, Hiroki Miura, Naoko Ishihara, Masaru Ihira, Yukitoshi Takahashi, Kazumi Matsuda, Tetsushi Yoshikawa
    JOURNAL OF INFECTIOUS DISEASES, 212(7) 1014-1021, Oct, 2015  Peer-reviewed
  • 竹内 智哉, 夏目 淳, 伊藤 祐史, 小川 千香子, 大野 敦子, 城所 博之, 石原 尚子, 根来 民子, 渡邊 一功
    てんかん研究, 33(2) 505-505, Sep, 2015  
  • 夏目 淳, 石原 尚子, 東 慶輝, 竹内 智哉, 伊藤 祐史, 小川 千香子, 坂口 陽子, 大野 敦子, 城所 博之, 根来 民子, 渡邊 一功
    てんかん研究, 33(2) 579-579, Sep, 2015  
  • 小川 千香子, 夏目 淳, 竹内 智哉, 伊藤 祐史, 大野 敦子, 城所 博之, 大萱 俊介, 倉橋 宏和, 辻 健史, 鈴木 基正, 久保田 哲夫, 服部 文子, 石原 尚子, 根来 民子, 渡邊 一功
    てんかん研究, 33(2) 578-578, Sep, 2015  
  • Yuji Ito, Jun Natsume, Hiroyuki Kidokoro, Naoko Ishihara, Yoshiteru Azuma, Takeshi Tsuji, Akihisa Okumura, Tetsuo Kubota, Naoki Ando, Shinji Saitoh, Kiyokuni Miura, Tamiko Negoro, Kazuyoshi Watanabe, Seiji Kojima
    EPILEPSIA, 56(8) 1286-1293, Aug, 2015  Peer-reviewed
  • 岡井 佑, 夏目 淳, 小川 千香子, 伊藤 裕史, 城所 博之, 石原 尚子, 東 慶輝, 竹内 智哉, 横井 摂理, 山本 啓之, 三浦 清邦, 根来 民子, 渡邊 一功
    脳と発達, 47(Suppl.) S228-S228, May, 2015  
  • 岡井 佑, 夏目 淳, 小川 千香子, 伊藤 祐史, 城所 博之, 石原 尚子, 東 慶輝, 竹内 智哉, 横井 摂理, 山本 啓之, 高田 弘幸, 三浦 清邦, 根来 民子, 渡邊 一功, 小島 勢二
    日本小児科学会雑誌, 119(3) 649-649, Mar, 2015  
  • 伊藤 祐史, 夏目 淳, 坂口 陽子, 小川 千香子, 竹内 智哉, 横井 摂理, 東 慶輝, 城所 博之, 石原 尚子, 三浦 清邦, 根来 民子, 渡邊 一功
    てんかん研究, 32(3) 608-608, Jan, 2015  
  • Natsume Jun, 小川 千香子, 山本 啓之, 伊藤 祐史, 竹内 智哉, 横井 摂理, 坂口 陽子, 東 慶輝, 石原 尚子, 城所 博之, 三浦 清邦, 根来 民子, 渡邊 一功
    てんかん研究, 32(2) 364-364, Sep, 2014  
  • 伊藤 祐史, 小川 千香子, 竹内 智哉, 横井 摂理, 東 慶輝, 城所 博之, 石原 尚子, 夏目 淳, 三浦 清邦, 根来 民子, 渡邊 一功
    てんかん研究, 32(2) 401-401, Sep, 2014  
  • Yasukazu Yamada, Noriko Nomura, Kenichiro Yamada, Mari Matsuo, Yuka Suzuki, Kiyoko Sameshima, Reiko Kimura, Yuto Yamamoto, Daisuke Fukushi, Yayoi Fukuhara, Naoko Ishihara, Eriko Nishi, George Imataka, Hiroshi Suzumura, Shin-Ichiro Hamano, Kenji Shimizu, Mie Iwakoshi, Kazunori Ohama, Akira Ohta, Hiroyuki Wakamoto, Mitsuharu Kajita, Kiyokuni Miura, Kenji Yokochi, Kenjiro Kosaki, Tatsuo Kuroda, Rika Kosaki, Yoko Hiraki, Kayoko Saito, Seiji Mizuno, Kenji Kurosawa, Nobuhiko Okamoto, Nobuaki Wakamatsu
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 164(8) 1899-1908, Aug, 2014  Peer-reviewed
  • 小川 千香子, 深沢 達也, 城所 博之, 石原 尚子, 東 慶輝, 横井 摂理, 山本 啓之, 竹内 智哉, 久保田 哲夫, 安藤 直樹, 三浦 清邦, 根来 民子, 渡邊 一功, 夏目 淳
    脳と発達, 46(Suppl.) S269-S269, May, 2014  
  • 城所 博之, 奥村 彰久, 辻 健史, 久保田 哲夫, 安藤 直樹, 伊藤 祐史, 小川 千香子, 山本 啓之, 石原 尚子, 加藤 徹, 早川 文雄, 齋藤 伸治, 夏目 淳
    脳と発達, 46(Suppl.) S252-S252, May, 2014  

Misc.

 22

Books and Other Publications

 2

Presentations

 17

Research Projects

 3

教育内容・方法の工夫(授業評価等を含む)

 3
  • 件名(英語)
    小児脳波判読実習に実際の脳波判読システムを利用した。
    開始年月日(英語)
    2010/04
    終了年月日(英語)
    2014/03
    概要(英語)
    実際の医療現場で使用されている脳波判読システムを用いることで、より実践的な実習が可能になった。
  • 件名(英語)
    小児てんかん学講義に、てんかん発作時のビデオを活用した。
    開始年月日(英語)
    2010/04
    終了年月日(英語)
    2014/03
    概要(英語)
    患者のビデオを用いることで、医療現場で立ち会う臨場感を得ることができた。
  • 件名(英語)
    重症心身障害児実習に、実際の患者・家族の参加を行った。
    開始年月日(英語)
    2010/04
    終了年月日(英語)
    2014/03
    概要(英語)
    在宅医療の現状を、家族とふれあいながら学ぶことで、より実践的な経験ができた。

作成した教科書、教材、参考書

 2
  • 件名(英語)
    発作時脳波からみた小児てんかん(診断と治療社)
    終了年月日(英語)
    2011/05/28
    概要(英語)
    症例提示pp53-56, pp71-77, pp84-93, pp118-122を分担執筆
  • 件名(英語)
    小児疾患の診断治療基準第4版(東京医学社)
    終了年月日(英語)
    2012/11/01
    概要(英語)
    糖輸送体1異常症(グルコーストランスポータ-1異常症),pp738-739を分担執筆

教育方法・教育実践に関する発表、講演等

 3
  • 件名(英語)
    第55回日本小児神経学会
    終了年月日(英語)
    2013/05
    概要(英語)
    家族参加型重症心身障害医学教育について共同演者として発表した。
  • 件名(英語)
    第45回日本医学教育学会大会
    開始年月日(英語)
    2013/07/26
    終了年月日(英語)
    2013/07/27
    概要(英語)
    障害児者専門医療機関における重症心身障害児(者)医療教育について共同演者として発表した。
  • 件名(英語)
    第116回日本小児科学会学術集会
    終了年月日(英語)
    2013/04
    概要(英語)
    医学部における重症心身障害医療教育に関するアンケート調査について共同演者として発表した。

その他教育活動上特記すべき事項

 2
  • 件名(英語)
    PBLチュータートレーニング
    終了年月日(英語)
    2010/04
    概要(英語)
    PBLチュータートレーニングに参加した。以後、PBLチューターをつとめている。
  • 件名(英語)
    卒後研修委員会
    開始年月日(英語)
    2013/09
    終了年月日(英語)
    2014/03
    概要(英語)
    卒後研修委員会に小児科委員として参加。卒後研修プログラムの作成、研修医の指導を行った。